Drugs Made In America Acquisition (DMIIR) Prepaid Assets (2024 - 2025)

Drugs Made In America Acquisition's (DMIIR) quarterly Prepaid Assets came in at $25814.0 in Q4 2025, down 39.38% year-on-year from $42580.0 in Q4 2024, and up 72.09% on a QoQ basis from $15000.0 in Q3 2025.

Drugs Made In America Acquisition (DMIIR) Prepaid Assets (2024 - 2025) Analysis & Trends

Drugs Made In America Acquisition (DMIIR) has 2 years of Prepaid Assets data on file, last reported at $25814.0 in Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 39.38% year-over-year to $25814.0 in Q4 2025; TTM through Dec 2025 was $25814.0, a 39.38% decrease from a year earlier, with the FY2025 full-year figure at $25814.0, down 39.38% from the prior year.
  • Prepaid Assets for Q4 2025 stood at $25814.0, up from $15000.0 in the prior quarter.
  • Over the last five years, Prepaid Assets for DMIIR reached as high as $42580.0 in Q4 2024 and fell as low as $15000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 EQV Ventures Acquisition 480.75 Mn 480.75 Mn -
2 Agriculture & Natural Solutions Acquisition 393.29 Mn 393.29 Mn -
3 Berto Acquisition 314.56 Mn 314.35 Mn -
4 GP-Act III Acquisition 313.66 Mn 313.66 Mn -
5 Centurion Acquisition 311.65 Mn 311.65 Mn -
6 Republic Digital Acquisition 310.50 Mn 309.63 Mn -
7 Siddhi Acquisition Corp (Cayman Islands) 288.97 Mn 288.97 Mn -
8 K&F Growth Acquisition 283.42 Mn 283.42 Mn -
9 Bold Eagle Acquisition 275.29 Mn 275.29 Mn -
10 Drugs Made In America Acquisition - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 25,814.00
Sep 30, 2025 15,000.00
Dec 31, 2024 42,580.00